NCT02981628 · Interventional trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Overall registry status Active not recruiting
Phase 2
Conditions Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia, Refractory B Lymphoblastic Lymphoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
- Saint Christopher's Hospital for Children · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory